CARM
Price
$0.40
Change
-$0.02 (-4.76%)
Updated
Jul 3 closing price
Capitalization
16.84M
ESLA
Price
$0.88
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
31.83M
Interact to see
Advertisement

CARM vs ESLA

Header iconCARM vs ESLA Comparison
Open Charts CARM vs ESLABanner chart's image
Carisma Therapeutics
Price$0.40
Change-$0.02 (-4.76%)
Volume$398.66K
Capitalization16.84M
Estrella Immunopharma
Price$0.88
Change-$0.00 (-0.00%)
Volume$16.94K
Capitalization31.83M
CARM vs ESLA Comparison Chart in %
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. ESLA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Buy and ESLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (CARM: $0.40 vs. ESLA: $0.88)
Brand notoriety: CARM and ESLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 2% vs. ESLA: 7%
Market capitalization -- CARM: $16.84M vs. ESLA: $31.83M
CARM [@Biotechnology] is valued at $16.84M. ESLA’s [@Biotechnology] market capitalization is $31.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileESLA’s FA Score has 0 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • ESLA’s FA Score: 0 green, 5 red.
According to our system of comparison, CARM is a better buy in the long-term than ESLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 5 TA indicator(s) are bullish while ESLA’s TA Score has 3 bullish TA indicator(s).

  • CARM’s TA Score: 5 bullish, 5 bearish.
  • ESLA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CARM is a better buy in the short-term than ESLA.

Price Growth

CARM (@Biotechnology) experienced а -0.84% price change this week, while ESLA (@Biotechnology) price change was -6.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLA($31.8M) has a higher market cap than CARM($16.8M). CARM YTD gains are higher at: -3.773 vs. ESLA (-26.667). ESLA has higher annual earnings (EBITDA): -8.82M vs. CARM (-49.68M). CARM has more cash in the bank: 7.74M vs. ESLA (421K). CARM has higher revenues than ESLA: CARM (20M) vs ESLA (0).
CARMESLACARM / ESLA
Capitalization16.8M31.8M53%
EBITDA-49.68M-8.82M564%
Gain YTD-3.773-26.66714%
P/E RatioN/AN/A-
Revenue20M0-
Total Cash7.74M421K1,838%
Total Debt2.33MN/A-
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARMESLA
RSI
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
63%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
59%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
73%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 21 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
89%
Aroon
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BREA7.690.14
+1.85%
Brera Holdings PLC
TROW100.150.19
+0.19%
T Rowe Price Group
ALE64.77N/A
N/A
ALLETE
IPHA1.82N/A
N/A
Innate Pharma SA
VIPS14.99-0.08
-0.53%
Vipshop Holdings Limited

CARM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARM has been loosely correlated with EVGN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CARM jumps, then EVGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARM
1D Price
Change %
CARM100%
-4.05%
EVGN - CARM
58%
Loosely correlated
-1.47%
INSM - CARM
40%
Loosely correlated
-0.45%
PMVP - CARM
33%
Loosely correlated
+8.18%
ABCL - CARM
31%
Poorly correlated
+1.33%
ADPT - CARM
31%
Poorly correlated
+2.79%
More

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and CARM have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and CARM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
-0.11%
CARM - ESLA
25%
Poorly correlated
-4.05%
RNA - ESLA
23%
Poorly correlated
-0.65%
FATE - ESLA
23%
Poorly correlated
N/A
CMND - ESLA
23%
Poorly correlated
+21.82%
IONS - ESLA
23%
Poorly correlated
-1.35%
More